Both in Biotechnology
Inhibrx Biosciences vs Novavax
Over the past year INBX returned +5.8% and NVAX returned +41.8%; their daily moves had a correlation of 0.22.
INBX +5.8% NVAX +41.8%Growth of $1, one year, split-adjusted
| Metric | INBX | NVAX |
|---|---|---|
| Price | $86.76 | $10.65 |
| Market cap | $1.28B | $1.76B |
| Today | +7.01% | +10.02% |
| 1 month | −7.1% | −5.9% |
| 6 months | −38.8% | +13.8% |
| Year to date | +9.8% | +58.5% |
| 1 year | +6.5% | +34.6% |
| Revenue growth (YoY) | −100.0% | −76.3% |
| Gross margin | — | 74.9% |
| Net margin | — | −94.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.2× |
| Net cash | -$42.9M | $422.0M |
| Dividend yield | — | — |
| Volatility (60d) | 88.8% | 82.7% |
| Short % of float | 35.5% | 30.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).